Skip to content

Kestra Medical Technologies, Ltd.: financial reference

Explore Kestra Medical Technologies, Ltd. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assetsAt date2026-04-30358,465,000USD2026-07-14
Total liabilitiesAt date2026-04-3098,807,000USD2026-07-14
Cash and cash equivalentsAt date2026-04-3099,710,000USD2026-07-14
Net income or loss2025-05-012026-04-30-131,612,000USD2026-07-14
Operating cash flow2025-05-012026-04-30-81,703,000USD2026-07-14
Capital expenditure payments2025-05-012026-04-3034,892,000USD2026-07-14
Contract revenue excluding tax2025-05-012026-04-3095,126,000USD2026-07-14
Financing cash flow2025-05-012026-04-30147,095,000USD2026-07-14
Investing cash flow2025-05-012026-04-30-203,277,000USD2026-07-14
Retained earnings or deficitAt date2026-04-30-651,861,000USD2026-07-14
Basic weighted-average shares2025-05-012026-04-3054,184,698shares2026-07-14
Diluted weighted-average shares2025-05-012026-04-3054,184,698shares2026-07-14
Basic earnings per share2025-05-012026-04-30-2.43USD/shares2026-07-14
Diluted earnings per share2025-05-012026-04-30-2.43USD/shares2026-07-14
Income tax expense or benefit2025-05-012026-04-30294,000USD2026-07-14
Net property, plant and equipmentAt date2026-04-3059,090,000USD2026-07-14
Share-based compensation expense2025-05-012026-04-3033,644,000USD2026-07-14
Operating income or loss2025-05-012026-04-30-134,741,000USD2026-07-14
Current assetsAt date2026-04-30222,359,000USD2026-07-14
Current liabilitiesAt date2026-04-3050,372,000USD2026-07-14
Current accounts payableAt date2026-04-3027,295,000USD2026-07-14
Operating expenses2025-05-012026-04-30183,604,000USD2026-07-14
Gross profit2025-05-012026-04-3048,863,000USD2026-07-14
Selling, general and administrative expense2025-05-012026-04-30164,120,000USD2026-07-14
Research and development expense2025-05-012026-04-3019,484,000USD2026-07-14

Inspect the source

Entity
Kestra Medical Technologies, Ltd. / CIK 0001877184
Captured
2026-09-21T17:34:30.641Z
SEC response SHA-256
349255c9a0b63038a49963b03c273268a4ab92a4aa83703220500dec893270fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001877184.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))